Search
for
Sort by
Research 901–930 of 1000+
- Gene Expression of Osteopontin in Alopecia Areata? A Case-Controlled Study
- Step-down approach to concentration of intra-lesional triamcinolone acetonide in treatment of scalp patchy alopecia areata: insights from an open-label randomized trial
- Real-world evidence in alopecia areata treatment: A narrative review
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the Kingdom of Saudi Arabia
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study
- Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study
- Impact of alopecia areata on quality of life assessed by the dermatology life quality index: a cross-sectional study at a tertiary care hospital in Peshawar
- Individualised homoeopathic treatment in alopecia areata: An evidence-based case series
- Knowledge, Beliefs, and Perceptions among Alopecia Areata Patients: A Cross-Sectional Study in CMH Kharian
- Rapid hair regrowth in alopecia totalis treated at Dr. Batra’s® homeopathy clinic: A classical homeopathic case report
- Beard hair response in Alopecia Areata Universalis treated with baricitinib
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24‐Week Outcomes From a Prospective Real‐World Cohort
- Revisión y avances en tricología
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial Program
- Complete Clinical and Trichoscopic Remission of Refractory Patch Alopecia Areata with a Multi-Modal Microneedling and Vitamin D3 Protocol: A Case Report
- Alopecia areata and adverse pregnancy outcomes: A systematic review and meta-analysis
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- NEW DEVELOPMENTS IN DERMOSCOPIC FEATURES OF ALOPECIA AREATA
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
- The Dermatologist is Out? Assessment of Dermatologists in Ontario Accepting Ontario Health Insurance Plan (OHIP) Referrals for Hair Loss Evaluation
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Serum Vitamin D Level in Pediatric Alopecia Areata